Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF-κB expressions
OLTULU, Fatih, BUHUR, Aylin, GÜREL, Çevik, KUŞÇU, Gökçe Ceren, DAĞDEVİREN, Melih, KARABAY YAVAŞOĞLU, Nefise Ülkü, KÖSE, Timur, YAVAŞOĞLU, AltuğVolume:
49
Language:
english
Journal:
TURKISH JOURNAL OF MEDICAL SCIENCES
DOI:
10.3906/sag-1901-15
Date:
October, 2019
File:
PDF, 1.30 MB
english, 2019